درباره این اپیزود
In this 192nd episode we take a closer look at a compound with a surprisingly long and fascinating history: methylene blue. Initially used as a textile dye in the 1800s, methylene blue has since found applications in medicine and surgery, and—more recently—conversations about mitochondrial function, energy production, and chronic illness.
My guest is Dr. Scott Sherr, an internal medicine physician, hyperbaric oxygen therapy specialist, Director of Education at HOMeHOPe, and Chief Medical and Health Education Officer at Troscriptions. Dr. Sherr brings a broad perspective to this topic, connecting the biochemistry of methylene blue with practical questions about chronic fatigue, fibromyalgia, autoimmunity, cancer-related fatigue, and mitochondrial support.
We’ll also discuss why Troscriptions uses a troche delivery system, how methylene blue may fit alongside hyperbaric oxygen therapy or red-light therapy, and—perhaps most importantly—where caution is needed. We’ll explore contraindications such as G6PD deficiency, potential medication and substance interactions, and questions surrounding methylene blue and psychedelic compounds, including classic psychedelics, ketamine, and MDMA.
And because wellness is never just about one molecule or one intervention, we’ll also talk about the nervous system. What does it mean to help someone move out of chronic sympathetic activation and toward a more parasympathetic, restorative state? And why might that shift be essential for healing, recovery, and resilience?
Let’s get into it with Dr. Scott Sherr.
Links & Websites:
Instagram: https://www.instagram.com/troscriptions/
https://www.instagram.com/drscottsherr/
https://www.instagram.com/onebasehealth/
https://www.instagram.com/homehopeorg/
Youtube: https://www.youtube.com/@troscriptions
https://www.youtube.com/@drscottsherr
Linked In: https://www.linkedin.com/in/drsherr/
https://www.linkedin.com/company/troscriptions/
